Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corbus Pharmaceuticals

8.83
-0.3400-3.71%
Post-market: 8.80-0.0300-0.34%19:00 EDT
Volume:98.22K
Turnover:876.50K
Market Cap:108.05M
PE:-2.09
High:9.16
Open:8.98
Low:8.80
Close:9.17
Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Rises 10.5%, Outperforms Competitors

Dow Jones
·
24 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
15 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Rallies 6.2%, Outperforms Competitors

Dow Jones
·
12 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
10 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
08 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
03 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
02 Apr

Corbus Pharmaceuticals Holdings Inc. Stock Slips 3.8%, Underperforms Competitors

Dow Jones
·
01 Apr

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist Crb-913 for the Treatment of Obesity

THOMSON REUTERS
·
28 Mar

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

GlobeNewswire
·
28 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
28 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
27 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Mar

Corbus Pharmaceuticals Announces Board Member Departure

TIPRANKS
·
22 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.2%, Underperforms Competitors

Dow Jones
·
22 Mar

After Plunging -22.69% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)

Zacks
·
20 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
19 Mar

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar